E. Anders Kolb, President and Chief Executive Officer of Blood Cancer United, shared on LinkedIn:
“Today Blood Cancer United is launching Dare to Dream REALworld: AML, an initiative designed to harness real-world evidence to accelerate research and, ultimately, bring better treatment options to children facing AML.
By securely sharing health records through the Olivia personal health concierge app, patients, survivors, and families can contribute to a growing dataset that helps researchers learn from real-world experiences, improve the design of future clinical trials, and potentially evaluate new therapies more efficiently.
Every record shared has the potential to deepen our understanding of pediatric AML and move discovery forward.
The future of cancer research will depend not only on scientific breakthroughs, but also on our ability to learn from every patient’s experience. Real-world evidence is an important part of that future, especially for rare diseases like pediatric AML, where every insight matters.
My thanks to Tempus AI for providing the technology that powers this effort and our co-founder Rally Foundation for Childhood Cancer Research for its early support in helping bring this vision to life.
If you’re a physician who treats pediatric AML, please help spread the word to eligible families. If your family has been impacted by pediatric AML, I encourage you to learn more and consider participating. You can learn more at the link in the comments.”
Huyong Zheng at LeukO 2026: Two Decades of Progress, a New Future for Pediatric AML
You can also read:
Time Toxicity in Acute Myeloid Leukemia Care and the Potential of All-Oral Therapy
